Visszatérés

Szolgáltatásink az alábbi országokban elérhetőek

Corporate

Európa:

Zászló Albánia Albánia Zászló Bosznia Herzegovina Bosznia Herzegovina Zászló Bulgária Bulgária Zászló Horvátország Horvátország Zászló Ciprus Ciprus Zászló Montenegró Montenegró Zászló Cseh Köztársaság Cseh Köztársaság Zászló Dánia Dánia Zászló Észtország Észtország Zászló Spanyolország Spanyolország Zászló Koszovó Koszovó Zászló Litvánia Litvánia Zászló Lettország Lettország Zászló Luxemburg Luxemburg Zászló Macedónia Macedónia Zászló Németország Németország Zászló Lengyelország  Lengyelország  Zászló Portugália Portugália Zászló Románia Románia Zászló Szerbia Szerbia Zászló Szlovákia Szlovákia Zászló Szlovénia Szlovénia Zászló Svájc Svájc Zászló Svédország Svédország Zászló Törökország Törökország Zászló Magyarország Magyarország Zászló Egyesült Királyság Egyesült Királyság Zászló Olaszország Olaszország

Ázsia:

Zászló UAE UAE Zászló Hong-Kong Hong-Kong Zászló Kuvait Kuvait Zászló Libanon Libanon

Afrika:

Zászló Dél-Afrika Dél-Afrika
Visszahívást kérek

Szeretne többet megtudni szolgáltasainkról?

Töltse ki az alábbi regisztrációs felületet és kollégáink hamarosan felveszik önnel a kapcsolatot, hogy válaszoljanak minden felmerülő kérdésére

    "Adatait semmilyen körülmények között nem tesszük harmadik fél számára hozzáférhetővé.

    Obraz

    Életmentő
    transzplantációk listája

    A Famicord csoport laboratóriumaiból kezelésre kiadott minták listája.

    Obraz
    Lp. Őssejt forrás Forrás típusa Diagnózis Érintett szakterület Kezelés éve Terápia Ország Páciens életkora
    901 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 5
    902 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 58
    903 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 34
    904 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 61
    905 Apheresis Allogeneic Myelodysplastic Syndrome/Myeloproliferative neoplasm Hematology 2025 Standard Therapy NETHERLANDS 62
    906 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Austria 68
    907 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 70
    908 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 66
    909 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 77
    910 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 12
    911 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 58
    912 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 67
    913 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 4
    914 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 73
    915 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 56
    916 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 50
    917 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 39
    918 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 43
    919 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy Poland 66
    920 Apheresis Allogeneic Multiple Myeloma Hematology 2025 Standard Therapy USA 61
    921 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Austria 55
    922 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 69
    923 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Denmark 67
    924 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy United Kingdom 75
    925 Apheresis Allogeneic T – cell Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 24
    926 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Belgium 68
    927 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Ukraine 42
    928 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 50
    929 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2025 Standard Therapy USA 62
    930 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy United Kingdom 62
    931 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy USA 69
    932 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 85
    933 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 54
    934 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 39
    935 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 45
    936 Apheresis Autologous Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 59
    937 Apheresis Allogeneic Multiple myeloma Hematology 2025 Standard Therapy Germany 68
    938 Apheresis Allogeneic Multiple myeloma Hematology 2025 Standard Therapy Germany 68
    939 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 73
    940 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 66
    941 Apheresis Autologous Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 69
    942 Apheresis Autologous Hodgkin lymphoma Hematology 2025 Standard Therapy Germany 38
    943 Apheresis Allogeneic Tcell acute leukemia Hematology 2025 Standard Therapy Romania 31
    944 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 37
    945 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Sweden 69
    946 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
    947 Apheresis Allogeneic Fanconi’s Anemia Hematology 2025 Standard Therapy Russia 14
    948 Apheresis Allogeneic Peripheral T-cell Lymphoma not otherwise specified Hematology 2025 Standard Therapy Germany 54
    949 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 63
    950 Apheresis Allogeneic Myeloid Sarcoma Hematology 2025 Standard Therapy Poland 48
    951 Apheresis Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2025 Standard Therapy USA 72
    952 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Germany 11
    953 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 37
    954 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Australia 59
    955 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 35
    956 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 51
    957 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 59
    958 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 70
    959 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 70
    960 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 66
    961 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
    962 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 66
    963 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Italy 61
    964 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
    965 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2025 Standard Therapy Czechia 45
    966 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Brazil 61
    967 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Hungary 35
    968 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 48
    969 Apheresis Allogeneic Mantle Cell Lymphoma Hematology 2025 Standard Therapy Ireland 62
    970 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 62
    971 Apheresis Allogeneic Acute Myeloid Leukemia, Myelodysplasia-Related Hematology 2025 Standard Therapy Russia 53
    972 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 56
    973 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 68
    974 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 70
    975 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 62
    976 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 53
    977 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 52
    978 Apheresis Autologous Diffuse large B-cell lymphoma Hematology 2025 Standard Therapy Germany 63
    979 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 72
    980 Apheresis Autologous Central nervous system lymphoma Hematology 2025 Standard Therapy Germany 64
    981 Apheresis Allogeneic Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 74
    982 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 65
    983 Apheresis Allogeneic T-cell prolymphocytic leukemia Hematology 2025 Standard Therapy Germany 53
    984 Apheresis Autologous Central nervous system lymphoma Hematology 2025 Standard Therapy Germany 70
    985 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 61
    986 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 54
    987 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 41
    988 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 32
    989 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 72
    990 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Poland 52
    991 Apheresis Allogeneic Chronic Myeloid Leukemia Hematology 2025 Standard Therapy Poland 50
    992 Apheresis Allogeneic T-cell Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 17
    993 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 66
    994 Apheresis Allogeneic Multiple Myeloma Hematology 2025 Standard Therapy Poland 49
    995 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2025 Standard Therapy Poland 5
    996 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 55
    997 Apheresis Allogeneic Diffuse Large B-cell Lymphoma Hematology 2025 Standard Therapy Poland 68
    998 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 64
    999 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 51
    1000 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 58